Literature DB >> 10925999

Anti-inflammatory effect of rebamipide enema on proctitis type ulcerative colitis: a novel therapeutic alternative.

K Makiyama, F Takeshima, H Kawasaki, W L Zea-Iriarte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10925999     DOI： 10.1111/j.1572-0241.2000.02154.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  14 in total

1.  Efficacy of rebamipide enemas in active distal ulcerative colitis and proctitis: a prospective study report.

Authors:  K Makiyama; F Takeshima; T Hamamoto
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

Review 2.  Wound healing of intestinal epithelial cells.

Authors:  Masahiro Iizuka; Shiho Konno
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

3.  Rebamipide promotes healing of colonic ulceration through enhanced epithelial restitution.

Authors:  Tomohisa Takagi; Yuji Naito; Kazuhiko Uchiyama; Toshimitsu Okuda; Katsura Mizushima; Takahiro Suzuki; Osamu Handa; Takeshi Ishikawa; Nobuaki Yagi; Satoshi Kokura; Hiroshi Ichikawa; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

4.  Rebamipide enemas-new effective treatment for patients with corticosteroid dependent or resistant ulcerative colitis.

Authors:  Mitsuki Miyata; Kunio Kasugai; Tetsuya Ishikawa; Shinichi Kakumu; Masafumi Onishi; Takeshi Mori
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

Review 5.  15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications.

Authors:  Tetsuo Arakawa; Kazuhide Higuchi; Yasuhiro Fujiwara; Toshio Watanabe; Kazunari Tominaga; Eiji Sasaki; Nobuhide Oshitani; Toshikazu Yoshikawa; Andrzej S Tarnawski
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

6.  Rebamipide enema is effective for treatment of experimental dextran sulfate sodium induced colitis in rats.

Authors:  Takako Nakashima; Takashi Maeda; Hisashi Nagamoto; Takeshi Kumakura; Masaaki Takai; Toyoki Mori
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

7.  Rebamipide suppresses diclofenac-induced intestinal permeability via mitochondrial protection in mice.

Authors:  Lei Diao; Qiao Mei; Jian-Ming Xu; Xiao-Chang Liu; Jing Hu; Juan Jin; Qiang Yao; Mo-Li Chen
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

8.  Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action?

Authors:  A S Tarnawski; J Chai; R Pai; S K Chiou
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

9.  Rebamipide enema therapy for left-sided ischemic colitis patients accompanied by ulcers: open label study.

Authors:  Satohiro Matsumoto; Kenichiro Tsuji; Satoshi Shirahama
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

10.  Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.

Authors:  Bei-Bei Huang; Guo-Feng Li; Jing-Hui Luo; Lian Duan; Kishimoto Nobuaki; Yamamoto Akira
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.